27.09.2014 Views

Program - Society of Toxicology

Program - Society of Toxicology

Program - Society of Toxicology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

44 th Annual Meeting<br />

and ToxExpo<br />

<strong>Program</strong> Description<br />

#1774 ESTROGEN INFLUENCES THE GROWTH OF<br />

CELLS THROUGH MODULATING THE<br />

INTRACELLULAR REDOX STATE. Q. Felty and<br />

D. Roy. Environmental & Occupational Health, Florida<br />

International University, Miami, FL.<br />

#1775 THE EFFECT OF POLYCHLORINATED<br />

BIPHENYLS (PCBs) ON THYROID HORMONE<br />

RECEPTOR (TR) AND CO-REGULATOR<br />

INTERACTIONS ON DNA. S. You 1 , K. Gauger 1 and<br />

R. Zoeller 2,1 . 1 Molecular & Cellular Biology <strong>Program</strong>,<br />

University <strong>of</strong> Massachusetts, Amherst, MA and<br />

2 Biology, University <strong>of</strong> Massachusetts, Amherst, MA.<br />

Wednesday Afternoon, March 9<br />

1:30 PM to 4:30 PM<br />

Exhibit Hall<br />

POSTER SESSION: PHARMACEUTICALS-METABOLIC/CANCER<br />

Chairperson(s): Thomas Mably, Bristol Meyers Squibb Co, Evansville, IN.<br />

Displayed: 1:30 PM–4:30 PM<br />

Attended: 1:30 PM–3:00 PM<br />

#1776 GENETIC TOXICOLOGY AND BONE MARROW<br />

CYTOTOXICITY STUDIES OF THE<br />

CORTICOTROPIN-RELEASING HORMONE<br />

(CRH) RECEPTOR ANTAGONIST,<br />

ANTALARMIN. P. T. Curry 1 , M. Nagabhushan 1 , D. L.<br />

McCormick 1 , R. E. Parchment 2 , K. Calis 3 , P. W. Gold 3 ,<br />

G. Cizza 3 , D. Charney 3 , E. R. Glaze 4 and J. E.<br />

Tomaszewski 4 . 1 IIT Research Institute, Chicago, IL,<br />

2 SciTech Development LLC, Grosse Pointe, MI,<br />

3 National Institute <strong>of</strong> Mental Health, Bethesda, MD and<br />

4 National Cancer Institute, Bethesda, MD.<br />

#1777 SUBCHRONIC ORAL TOXICITY OF THE<br />

CORTICOTROPIN-RELEASING HORMONE<br />

(CRH) RECEPTOR ANTAGONIST,<br />

ANTALARMIN, IN DOGS. W. D. Johnson 1 , J.<br />

Harder 1 , D. L. McCormick 1 , R. L. Morrissey 2 , K.<br />

Calis 3 , P. W. Gold 3 , G. Cizza 3 , D. Charney 3 , E. R.<br />

Glaze 4 and J. E. Tomaszewski 4 . 1 IIT Research Institute,<br />

Chicago, IL, 2 Pathology Associates, Chicago, IL,<br />

3 National Institute <strong>of</strong> Mental Health, Bethesda, MD and<br />

4 National Cancer Institute, Bethesda, MD.<br />

#1778 SUBCHRONIC ORAL TOXICITY OF THE<br />

CORTICOTROPIN-RELEASING HORMONE<br />

(CRH) RECEPTOR ANTAGONIST,<br />

ANTALARMIN, IN RATS. T. L. Horn 1 , W. D.<br />

Johnson 1 , D. L. McCormick 1 , R. L. Morrissey 2 , K.<br />

Calis 3 , P. W. Gold 3 , G. Cizza 3 , D. Charney 3 , E. R.<br />

Glaze 4 and J. E. Tomaszewski 4 . 1 IIT Research Institute,<br />

Chicago, IL, 2 Pathology Associates, Chicago, IL,<br />

3 National Institute <strong>of</strong> Mental Health, Bethesda, MD and<br />

4 National Cancer Institute, Bethesda, MD.<br />

#1780 REPEAT DOSE TOXICITY STUDIES IN RATS<br />

AND DOGS WITH TH0318, A DPP IV-RESISTANT<br />

ANALOG OF NATURAL GLP-1. S. Fennell 1 , H.<br />

Loughrey 1 , M. Garino 1 , S. Abdullah 1 , M. Stilianesis 2 ,<br />

K. Arjah 2 , B. Vu 2 and E. Ferdinandi 1 .<br />

1 Theratechnologies, Inc., Saint Laurent (Montreal), QC,<br />

Canada and 2 CTBR Bio-Research Inc., Senneville, QC,<br />

Canada. Sponsor: C. Banks.<br />

#1781 CARCINOGENICITY EVALUATION OF<br />

ATAZANAVIR IN MICE. T. A. Mably 1 , T. P.<br />

Sanderson 1 , C. D. Houle 2 , B. E. Schilling 1 and M. A.<br />

Dominick 1 . 1 Drug Safety Evaluation, Bristol-Myers<br />

Squibb Co., Mt.Vernon, IN and 2 Experimental<br />

Pathology Laboratories, Inc., Research Triangle Park,<br />

NC.<br />

#1782 MULTIPLE DOSE TOXICITY STUDY OF<br />

IMEXON IN FISCHER 344 RATS. Y. Chen 1 , E.<br />

Glaze 2 , J. Tomaszewski 2 , R. Morrissey 3 and A.<br />

Lyubimov 1 . 1 <strong>Toxicology</strong> Research Laboratory,<br />

University <strong>of</strong> Illinois at Chicago, Chicago, IL, 2 Division<br />

<strong>of</strong> Cancer Treatment and Diagnosis, National Cancer<br />

Institute, Bethesda, MD and 3 Pathology Associates<br />

Division, Charles River Laboratories, Chicago, IL.<br />

#1783 SEQUENCE DEPENDENT ANTAGONISM<br />

BETWEEN RALOXIFENE, 5-FLUOROURACIL<br />

AND PEMETREXED. E. Fryar 1 , D. H. Jillian 1 , S. M.<br />

William 2 and B. Donnell 1 . 1 Pharmacology, Howard<br />

University, Washington, DC and 2 Biochemistry, Howard<br />

University, Washington, DC.<br />

#1784 UTILIZATION OF MULTIPLE ENDPOINTS TO<br />

INVESTIGATE DIFFERENTIAL TOXICITY<br />

PRODUCED BY TOPOISOMERASE II<br />

INHIBITORS, DOXORUBICIN AND ETOPOSIDE.<br />

R. T. Dunn, E. S. Galambos, L. Healy, R. Morgan, J.<br />

Yamada, H. Hamadeh, A. Kwok, M. E. Cosenza and C.<br />

Afshari. <strong>Toxicology</strong>, Amgen Inc., Thousand Oaks, CA.<br />

#1785 ORAL TOXICITY STUDY OF A RETINOIC ACID<br />

ANALOGUE, 9-CIS-UAB-30, IN RATS. R.<br />

Krishnaraj 1 , A. Lyubimov 1 , C. Detrisac 2 , I.<br />

Kapetanovic 3 , J. Crowell 3 , W. Brouillette 4 and D.<br />

Muccio 4 . 1 Pharmacology, University <strong>of</strong> Illinois at<br />

Chicago, Chciago, IL, 2 Pathology Associates, Chciago,<br />

IL, 3 National Cancer Institute, Bethesda, MD and<br />

4 Chemistry, University <strong>of</strong> Alabama at Birmingham,<br />

Birmingham, AL.<br />

WEDNESDAY<br />

#1779 CYPROHEPTADINE AND CYCLIZINE INHIBIT<br />

INSULIN SECRETION IN RIN5F CELLS BY<br />

INHIBITING CALCIUM CHANNELS. M. Otieno 1 , N.<br />

Bavuso 1 , A. Katein 1 , T. Kelly 1 , J. Milano 1 and F.<br />

Pognan 2 . 1 Safety Assessment US, AstraZeneca<br />

Pharmaceuticals, Wilmington, DE and 2 Safety<br />

Assessment UK, AstraZeneca Pharmaceuticals, Alderly<br />

Park, United Kingdom.<br />

up-to-date information at www.toxicology.org 185

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!